Amundi Has $4.87 Million Stock Position in Bath & Body Works, Inc. $BBWI

Key Points

• Amundi significantly increased its holdings in Bath & Body Works by 382.1%, acquiring an additional 138,664 shares during the first quarter, bringing its total ownership to 174,951 shares valued at approximately $4.87 million.
• Bath & Body Works reported quarterly earnings of $0.37 per share, meeting analysts’ expectations, with a revenue of $1.55 billion, indicating a slight decline of 0.8% compared to the previous year.
• The company announced a quarterly dividend of $0.20 per share with a 2.8% yield, paid on September 5, and has a dividend payout ratio of 23.74%.

Amundi grew its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 382.1% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 174,951 shares of the company's stock after purchasing an additional 138,664 shares during the period. Amundi owned approximately 0.08% of Bath & Body Works worth $4,872,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Bath & Body Works by 38.9% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 41,711 shares of the company's stock valued at $1,265,000 after purchasing an additional 11,681 shares in the last quarter. Merit Financial Group LLC purchased a new stake in shares of Bath & Body Works during the first quarter worth $714,000. Nuveen Asset Management LLC raised its holdings in shares of Bath & Body Works by 3.7% during the fourth quarter. Nuveen Asset Management LLC now owns 764,195 shares of the company's stock worth $29,628,000 after acquiring an additional 27,136 shares in the last quarter. Assenagon Asset Management S.A. raised its holdings in shares of Bath & Body Works by 3,642.2% during the first quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company's stock worth $50,062,000 after acquiring an additional 1,606,988 shares in the last quarter. Finally, Tremblant Capital Group purchased a new stake in shares of Bath & Body Works during the fourth quarter worth $6,891,000. Hedge funds and other institutional investors own 95.14% of the company's stock.

Bath & Body Works Stock Performance

Shares of Bath & Body Works stock traded down $0.64 during trading on Friday, reaching $27.23. The company's stock had a trading volume of 5,150,677 shares, compared to its average volume of 6,665,161. The business's fifty day moving average price is $30.31 and its 200-day moving average price is $30.17. The firm has a market cap of $5.61 billion, a price-to-earnings ratio of 8.08, a price-to-earnings-growth ratio of 0.95 and a beta of 1.49. Bath & Body Works, Inc. has a one year low of $24.94 and a one year high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Thursday, August 28th. The company reported $0.37 EPS for the quarter, hitting analysts' consensus estimates of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The business had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. During the same period in the previous year, the company posted $0.37 earnings per share. The firm's revenue for the quarter was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Sell-side analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 22nd were paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 2.9%. The ex-dividend date was Friday, August 22nd. Bath & Body Works's payout ratio is currently 23.74%.

Analyst Ratings Changes

BBWI has been the subject of several recent research reports. Morgan Stanley cut their price objective on Bath & Body Works from $19.00 to $18.00 and set an "overweight" rating for the company in a report on Friday. UBS Group lowered their target price on shares of Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating on the stock in a research report on Friday, August 29th. Citigroup lowered their target price on shares of Bath & Body Works from $42.00 to $40.00 and set a "buy" rating on the stock in a research report on Tuesday, August 19th. Barclays increased their target price on shares of Bath & Body Works from $30.00 to $32.00 and gave the stock an "equal weight" rating in a research report on Friday, August 29th. Finally, JPMorgan Chase & Co. increased their target price on shares of Bath & Body Works from $40.00 to $46.00 and gave the stock an "overweight" rating in a research report on Monday, July 28th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Bath & Body Works currently has an average rating of "Moderate Buy" and a consensus price target of $39.69.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.